Green Formulation of Descurainia sophia Aqueous Extract Mediated Ag NPs and Determination of Its Anti-Hemangioma Effects

Hemangioma is a common cancer with severe clinical signs. Finding a new anti-hemangioma supplement or drug inside of the chemotherapeutic drug is valuable. We synthesized silver nanoparticles containing Descurainia sophia leaf for investigating the anti-hemangioma, cytotoxicity, and antioxidant effects. Characterization of AgNPs was performed by Field Emission Scanning Electron Microscopy (FE-SEM), UV–Visible Spectroscopy (UV-Vis), and X-Ray diffraction analysis (XRD). The plain peak in the wavelength 449 nm revealed the AgNPs synthesis. TEM and FE-SEM analyses showed that synthesized AgNPs were found to be 16.9 to 48.43 nm mean particle size. For investigating the antioxidant efficacy, the DPPH assay was conducted. AgNPs prevented 50% of DPPH in the dilation of 40 μg/mL. To measure the anti-hemangioma efficacy of AgNPs, MTT assay was applied on SK HEP-1 and HAEND cell lines. AgNPs had high anti-hemangioma efficacy on above tumor cells without any significant toxicity on HUVEC. The best finding of anti-hemangioma properties of AgNPs was seen in the case of the HAEND cell line. This study indicated significant anti-hemangioma and antioxidant potentials of AgNPs containing Descurainia sophia.